Fundraising FoxFlarin
3 known investors
Find your way into Flarin
Sign up to see every warm intro you have to Flarin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flarin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Flarin is a consumer over-the-counter pain relief product that encases 200mg ibuprofen in a lipid-based formulation (Lipid Lock technology) intended to relieve joint, muscular, rheumatic and other common pains. It is sold to UK consumers through online pharmacies.
Investors · 3
Salica Investmentslisted by Salica InvestmentsLondon
How we know: the Companies House PSC register · salicainvestments.com · Not right? Tell us
Companies House · registry record
View on Companies House ↗- Registered name
- FLARIN HOLDINGS LIMITED
- Company number
- 11814774
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 8 Feb 2019
- Registered office
- 20 Little Britain, London, EC1A 7DH
- Nature of business (SIC)
- 64209 — Activities of other holding companies n.e.c.
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 Feb 2026 · next due 21 Feb 2027
Current officers · 4
- Alan Edward Armstrong — director, appointed 18 Feb 2020
- Kimbell Rush Duncan — director, appointed 4 Jun 2026
- Philip Edmund Lindsell — director, appointed 6 Mar 2019
- Erhard Manfred Scheske — director, appointed 3 Apr 2019
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Flarin do?
- Flarin is a consumer over-the-counter pain relief product that encases 200mg ibuprofen in a lipid-based formulation (Lipid Lock technology) intended to relieve joint, muscular, rheumatic and other common pains. It is sold to UK consumers through online pharmacies.
- Who are Flarin's investors?
- Flarin's investors include Salica Investments, ITV AdVentures, IW Capital.